Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells. [electronic resource]
Producer: 20141209Description: 2132-8 p. digitalISSN:- 1791-2423
- Aldehyde Dehydrogenase -- genetics
- Aldehyde Dehydrogenase 1 Family
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Dasatinib
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Pancreatic Neoplasms -- drug therapy
- Pyrimidines -- pharmacology
- Retinal Dehydrogenase
- Thiazoles -- pharmacology
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.